539 related articles for article (PubMed ID: 34904301)
41. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
[TBL] [Abstract][Full Text] [Related]
42. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
43. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
Wang H; Xu B; Shi J
Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
[TBL] [Abstract][Full Text] [Related]
44. EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis.
Lang F; Singh RK; Pei Y; Zhang S; Sun K; Robertson ES
PLoS Pathog; 2019 Jun; 15(6):e1007796. PubMed ID: 31226160
[TBL] [Abstract][Full Text] [Related]
45. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.
Xu Y; Yuan XD; Wu JJ; Chen RY; Xia L; Zhang M; Han CH; Mou S
J Cell Biochem; 2020 Jan; 121(1):524-533. PubMed ID: 31318098
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of m
Guimarães-Teixeira C; Lobo J; Miranda-Gonçalves V; Barros-Silva D; Martins-Lima C; Monteiro-Reis S; Sequeira JP; Carneiro I; Correia MP; Henrique R; Jerónimo C
Mol Oncol; 2022 May; 16(9):1841-1856. PubMed ID: 35048498
[TBL] [Abstract][Full Text] [Related]
47. METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis.
He M; Lei H; He X; Liu Y; Wang A; Ren Z; Liu X; Yan G; Wang W; Wang Y; Li G; Wang T; Pu J; Shen Z; Wang Y; Xie J; Du W; Yuan Y; Yang L
Stem Cells Transl Med; 2022 Sep; 11(9):987-1001. PubMed ID: 35980318
[TBL] [Abstract][Full Text] [Related]
48. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
Feng Z; Li Q; Meng R; Yi B; Xu Q
J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
[TBL] [Abstract][Full Text] [Related]
49. Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.
Yin L; Ma C; Hou S; Ma X
Bioengineered; 2022 Mar; 13(3):4773-4785. PubMed ID: 35139773
[TBL] [Abstract][Full Text] [Related]
50. The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes.
Arcidiacono OA; Krejčí J; Bártová E
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143367
[TBL] [Abstract][Full Text] [Related]
51. Arginine methylation of METTL14 promotes RNA N
Liu X; Wang H; Zhao X; Luo Q; Wang Q; Tan K; Wang Z; Jiang J; Cui J; Du E; Xia L; Du W; Chen D; Xia L; Xiao S
Nat Commun; 2021 Jun; 12(1):3780. PubMed ID: 34145242
[TBL] [Abstract][Full Text] [Related]
52. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
53. Ibuprofen promotes p75 neurotrophin receptor expression through modifying promoter methylation and N6-methyladenosine-RNA-methylation in human gastric cancer cells.
Jin H; Wu Z; Tan B; Liu Z; Zu Z; Wu X; Bi Y; Hu X
Bioengineered; 2022 Jun; 13(6):14595-14604. PubMed ID: 35758042
[TBL] [Abstract][Full Text] [Related]
54. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
55. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
56. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
57. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy.
Xiang M; Liu W; Tian W; You A; Deng D
Epigenomics; 2020 May; 12(9):801-809. PubMed ID: 32515221
[No Abstract] [Full Text] [Related]
58. m
Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
[TBL] [Abstract][Full Text] [Related]
59. m
Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
[TBL] [Abstract][Full Text] [Related]
60. A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth.
Miyake K; Costa Cruz PH; Nagatomo I; Kato Y; Motooka D; Satoh S; Adachi Y; Takeda Y; Kawahara Y; Kumanogoh A
Cell Rep; 2023 Jul; 42(7):112688. PubMed ID: 37355987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]